These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35721311)
1. Socioeconomic disparities in use of rhythm control therapies in patients with incident atrial fibrillation: A Finnish nationwide cohort study. Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Luojus A; Itäinen-Strömberg S; Hartikainen J; Aro AL; Juhani Airaksinen KE; Lehto M Int J Cardiol Heart Vasc; 2022 Aug; 41():101070. PubMed ID: 35721311 [TBL] [Abstract][Full Text] [Related]
2. Rural-Urban differences in Use of Rhythm Control Therapies in Patients with Incident Atrial Fibrillation: A Finnish Nationwide Cohort Study. Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Luojus A; Itäinen-Strömberg S; Hartikainen J; Aro AL; Airaksinen KEJ; Lehto M Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141456 [No Abstract] [Full Text] [Related]
3. Mental health conditions and use of rhythm control therapies in patients with atrial fibrillation: a nationwide cohort study. Teppo K; Jaakkola J; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Luojus A; Itäinen-Strömberg S; Penttilä T; Niemi M; Hartikainen J; Airaksinen KJ; Lehto M BMJ Open; 2022 Aug; 12(8):e059759. PubMed ID: 36041755 [TBL] [Abstract][Full Text] [Related]
4. Association of income and educational levels on initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study. Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Hartikainen J; Airaksinen KEJ; Lehto M Br J Clin Pharmacol; 2023 Jan; 89(1):351-360. PubMed ID: 35986926 [TBL] [Abstract][Full Text] [Related]
5. Association of income and educational levels with adherence to direct oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study. Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Tiili P; Lehtonen O; Niemi M; Mustonen P; Kinnunen J; Hartikainen J; Airaksinen KEJ; Lehto M Pharmacol Res Perspect; 2022 Jun; 10(3):e00961. PubMed ID: 35599338 [TBL] [Abstract][Full Text] [Related]
6. Socioeconomic factors and bleeding events in patients with incident atrial fibrillation: A Finnish nationwide cohort study. Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Putaala J; Mustonen P; Kinnunen J; Jolkkonen S; Niemi M; Hartikainen J; Airaksinen KEJ; Lehto M Int J Cardiol Heart Vasc; 2022 Dec; 43():101131. PubMed ID: 36246774 [TBL] [Abstract][Full Text] [Related]
7. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation. Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232 [TBL] [Abstract][Full Text] [Related]
8. Income and outcomes of patients with incident atrial fibrillation. Biancari F; Teppo K; Jaakkola J; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Hartikainen J; Aro A; Airaksinen J; Lehto M J Epidemiol Community Health; 2022 Jun; 76(8):736-42. PubMed ID: 35705362 [TBL] [Abstract][Full Text] [Related]
9. Ablation for atrial fibrillation: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(7):1-63. PubMed ID: 23074498 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: a cohort analysis on administrative data. Van Brabandt H; Neyt M; Devos C Europace; 2013 May; 15(5):663-8. PubMed ID: 23388182 [TBL] [Abstract][Full Text] [Related]
11. Bayesian network meta-analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillation. Elsayed M; Abdelfattah OM; Sayed A; Prasad RM; Barakat AF; Elgendy IY; Andrade J; Jared Bunch T; Thosani A; Saliba WI; Wazni OM; Hussein AA J Cardiovasc Electrophysiol; 2022 Feb; 33(2):197-208. PubMed ID: 34855270 [TBL] [Abstract][Full Text] [Related]
12. [The effectiveness of radiofrequency ablation and repeated cardioversion in combination with antiarrhythmic drug therapy in maintaining stable sinus rhythm in patients with atrial fibrillation and heart failure]. Seliutskii SI; Savina NM; Chapurnykh AV Kardiologiia; 2020 Sep; 60(8):90-97. PubMed ID: 33155964 [TBL] [Abstract][Full Text] [Related]
13. Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis. Xu X; Alida CT; Yu B Cardiovasc Ther; 2015 Aug; 33(4):242-6. PubMed ID: 26031448 [TBL] [Abstract][Full Text] [Related]
14. The Effects of Catheter Ablation Therapy on Medication Use and Expenditures in Patients with Atrial Fibrillation. Reynolds MR; David G; Gunnarsson C; March JL; Hao SC J Health Econ Outcomes Res; 2014; 2(1):15-28. PubMed ID: 34414245 [No Abstract] [Full Text] [Related]
15. Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation. Igarashi M; Tada H; Sekiguchi Y; Yamasaki H; Arimoto T; Kuroki K; Machino T; Murakoshi N; Aonuma K Am J Cardiol; 2010 Jul; 106(1):62-8. PubMed ID: 20609649 [TBL] [Abstract][Full Text] [Related]
16. Race and Ethnic and Sex Differences in Rhythm Control Treatment of Incident Atrial Fibrillation. Jackson Ii LR; Friedman DJ; Francis DM; Maccioni S; Thomas VC; Coplan P; Khanna R; Wong C; Rahai N; Piccini JP Clinicoecon Outcomes Res; 2023; 15():387-395. PubMed ID: 37273820 [TBL] [Abstract][Full Text] [Related]
17. Time to cardioversion of recurrent atrial arrhythmias after catheter ablation of atrial fibrillation and long-term clinical outcome. Baman TS; Gupta SK; Billakanty SR; Ilg KJ; Good E; Crawford T; Jongnarangsin K; Ebinger M; Pelosi F; Bogun F; Chugh A; Morady F; Oral H J Cardiovasc Electrophysiol; 2009 Dec; 20(12):1321-5. PubMed ID: 19602031 [TBL] [Abstract][Full Text] [Related]
18. Use of antiarrhythmic drugs during ablation of persistent atrial fibrillation: observations from a large single-centre cohort. Lüker J; Sultan A; Sehner S; Hoffmann B; Servatius H; Willems S; Steven D Heart Vessels; 2016 Oct; 31(10):1669-75. PubMed ID: 26546306 [TBL] [Abstract][Full Text] [Related]
19. Impact of postprocedural antiarrhythmic drug therapy with bepridil on maintaining sinus rhythm after catheter ablation for persistent atrial fibrillation. Kondo T; Miake J; Kato M; Ogura K; Iitsuka K; Yamamoto K J Cardiol; 2016 Sep; 68(3):229-35. PubMed ID: 26654806 [TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation. Waks JW; Zimetbaum P J Cardiovasc Pharmacol Ther; 2017 Jan; 22(1):3-19. PubMed ID: 27260643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]